Bnp Paribas Arbitrage Sa Decreased Its Moneygram Intl (MGI) Position; Biogen (BIIB) Shorts Raised By 8.22%

January 14, 2018 - By Peter Erickson

Biogen Incorporated (NASDAQ:BIIB) had an increase of 8.22% in short interest. BIIB’s SI was 3.68M shares in January as released by FINRA. Its up 8.22% from 3.40 million shares previously. With 983,600 avg volume, 4 days are for Biogen Incorporated (NASDAQ:BIIB)’s short sellers to cover BIIB’s short positions. The SI to Biogen Incorporated’s float is 1.74%. The stock increased 0.86% or $2.88 during the last trading session, reaching $335.95. About 885,516 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since January 14, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Bnp Paribas Arbitrage Sa decreased Moneygram Intl Inc (MGI) stake by 15.21% reported in 2017Q3 SEC filing. Bnp Paribas Arbitrage Sa sold 1,056 shares as Moneygram Intl Inc (MGI)’s stock rose 32.68%. The Bnp Paribas Arbitrage Sa holds 5,886 shares with $94.82 million value, down from 6,942 last quarter. Moneygram Intl Inc now has $686.76M valuation. The stock increased 3.86% or $0.47 during the last trading session, reaching $12.65. About 2.83M shares traded or 177.25% up from the average. MoneyGram International, Inc. (NASDAQ:MGI) has risen 183.58% since January 14, 2017 and is uptrending. It has outperformed by 166.88% the S&P500.

Since January 9, 2018, it had 0 insider purchases, and 1 sale for $1.92 million activity. 5,832 shares valued at $1.92 million were sold by PANGIA ROBERT W on Tuesday, January 9.

Among 31 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 22 have Buy rating, 0 Sell and 9 Hold. Therefore 71% are positive. Biogen Idec Inc. had 95 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Hold” rating by Morgan Stanley on Wednesday, June 14. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Overweight” rating by Piper Jaffray on Thursday, November 5. The stock of Biogen Inc. (NASDAQ:BIIB) has “Outperform” rating given on Monday, November 7 by Leerink Swann. Jefferies maintained the stock with “Hold” rating in Wednesday, August 30 report. BMO Capital Markets maintained Biogen Inc. (NASDAQ:BIIB) on Monday, November 27 with “Buy” rating. Credit Suisse initiated the shares of BIIB in report on Wednesday, January 20 with “Neutral” rating. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Buy” rating by Bank of America on Wednesday, October 18. Guggenheim initiated Biogen Inc. (NASDAQ:BIIB) rating on Monday, October 23. Guggenheim has “Buy” rating and $402.0 target. The company was initiated on Tuesday, August 11 by H.C. Wainwright. BMO Capital Markets downgraded the shares of BIIB in report on Friday, July 24 to “Market Perform” rating.

Investors sentiment increased to 1.13 in 2017 Q3. Its up 0.25, from 0.88 in 2017Q2. It is positive, as 59 investors sold Biogen Inc. shares while 283 reduced holdings. 96 funds opened positions while 292 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Geode Mngmt Lc has invested 0.28% in Biogen Inc. (NASDAQ:BIIB). M&T National Bank accumulated 0.13% or 75,445 shares. Wesbanco Bancorp Inc has 1,469 shares for 0.02% of their portfolio. Moreover, Hotchkis & Wiley Cap Management Ltd Limited Liability Company has 0.34% invested in Biogen Inc. (NASDAQ:BIIB). Chevy Chase owns 199,832 shares or 0.28% of their US portfolio. New York-based Etrade Capital Mgmt Limited Company has invested 0.09% in Biogen Inc. (NASDAQ:BIIB). Reynders Mcveigh Cap Mngmt Limited holds 4,675 shares. Nippon Life Insurance accumulated 7,628 shares or 0.04% of the stock. First Midwest National Bank & Trust Trust Division has invested 0.11% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Moreover, Great West Life Assurance Company Can has 0.17% invested in Biogen Inc. (NASDAQ:BIIB) for 220,116 shares. Epoch Invest Inc accumulated 0.01% or 7,162 shares. Strategic Global Ltd Liability Com owns 1,848 shares or 0.22% of their US portfolio. Pdts Prtn Limited Liability stated it has 0.44% in Biogen Inc. (NASDAQ:BIIB). Wealthtrust invested in 0% or 10 shares. Mitchell Capital Com holds 2.17% or 18,965 shares.

Biogen Inc., a biopharmaceutical company, discovers, develops, makes, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company has market cap of $71.05 billion. The firm offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis ; FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It has a 20.64 P/E ratio. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies.

Bnp Paribas Arbitrage Sa increased Copa Holdings Sa (NYSE:CPA) stake by 7,228 shares to 29,384 valued at $3.66B in 2017Q3. It also upped First Comwlth Finl Corp Pa (NYSE:FCF) stake by 27,332 shares and now owns 55,800 shares. Axon Enterprise Inc was raised too.

Among 8 analysts covering Moneygram International (NASDAQ:MGI), 1 have Buy rating, 2 Sell and 5 Hold. Therefore 13% are positive. Moneygram International had 12 analyst reports since August 3, 2015 according to SRatingsIntel. First Analysis downgraded MoneyGram International, Inc. (NASDAQ:MGI) on Thursday, January 26 to “Equal-Weight” rating. As per Wednesday, October 11, the company rating was maintained by Northland Capital. The rating was downgraded by Feltl & Co on Monday, January 30 to “Hold”. The rating was maintained by Northland Capital on Tuesday, July 18 with “Hold”. The stock of MoneyGram International, Inc. (NASDAQ:MGI) earned “Neutral” rating by Compass Point on Monday, November 2. The rating was maintained by Northland Capital with “Hold” on Monday, July 24. The firm earned “Hold” rating on Thursday, June 29 by Northland Capital. On Monday, August 3 the stock rating was upgraded by Evercore to “Sell”. Northland Capital maintained the stock with “Hold” rating in Tuesday, September 5 report. J.P. Morgan downgraded the shares of MGI in report on Tuesday, December 12 to “Sell” rating.

Investors sentiment decreased to 0.81 in Q3 2017. Its down 0.56, from 1.37 in 2017Q2. It dropped, as 21 investors sold MGI shares while 31 reduced holdings. 16 funds opened positions while 26 raised stakes. 46.30 million shares or 3.00% less from 47.73 million shares in 2017Q2 were reported. Manufacturers Life Insurance Com The accumulated 0% or 23,797 shares. State Board Of Administration Of Florida Retirement System accumulated 35,898 shares or 0% of the stock. Deutsche National Bank Ag reported 0.01% stake. Metropolitan Life Insur Ny holds 0% of its portfolio in MoneyGram International, Inc. (NASDAQ:MGI) for 21,334 shares. First Quadrant Limited Partnership Ca has 0% invested in MoneyGram International, Inc. (NASDAQ:MGI). Sit Associates has invested 0% in MoneyGram International, Inc. (NASDAQ:MGI). Quantbot Tech Lp invested 0.04% of its portfolio in MoneyGram International, Inc. (NASDAQ:MGI). Sg Americas owns 560,964 shares for 0.08% of their portfolio. Legal & General Group Inc Public Limited Com invested in 0% or 7,425 shares. Victory Mngmt invested in 9,011 shares or 0% of the stock. Magnetar Fincl Limited Liability Com accumulated 1.27 million shares. 125 were reported by Oakworth Capital. Indexiq Advisors Lc has 0.05% invested in MoneyGram International, Inc. (NASDAQ:MGI) for 72,263 shares. Natl Bank Of Ny Mellon owns 161,828 shares. Manitoba – Canada-based Great West Life Assurance Can has invested 0% in MoneyGram International, Inc. (NASDAQ:MGI).

Analysts await MoneyGram International, Inc. (NASDAQ:MGI) to report earnings on March, 21. They expect $0.19 EPS, up 18.75% or $0.03 from last year’s $0.16 per share. MGI’s profit will be $10.31M for 16.64 P/E if the $0.19 EPS becomes a reality. After $0.21 actual EPS reported by MoneyGram International, Inc. for the previous quarter, Wall Street now forecasts -9.52% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts